Nabriva Therapeutics plc (NBRV:NASDAQ) soared at $0.27, representing a gain of 39.4%. On Thu, Sep 15, 2022, NBRV:NASDAQ touched a New 2-Week High of $0.27. The stock appeared on our News Catalysts scanner on Thu, Sep 15, 2022 at 07:57 AM in the 'SPLIT' category. From Thu, Sep 01, 2022, the stock recorded 33.33% Up Days and 10.00% Green Days
The stock spiked on Thu, Sep 15, 2022 at $0.34 with a volume of 102M+.
About Nabriva Therapeutics plc (NBRV:NASDAQ)
Nabriva Therapeutics AG is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics.
Top 10 Gainers:
- The ExOne Company (XONE:NASDAQ), 87.17%
- BioTelemetry, Inc. (BEAT:NASDAQ), 85.6%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 47.21%
- Nabriva Therapeutics plc (NBRV:NASDAQ), 39.41%
- ChinaNet Online Holdings, Inc. (CNET:NASDAQ), 37.4%
- ZeroFox Holdings Inc. (ZFOX:NASDAQ), 32.65%
- Secoo Holding Limited (SECO:NASDAQ), 27.27%
- Getty Images Holdings Inc. Class A (GETY:NYSE), 25.71%
- Comera Life Sciences Holdings Inc. (CMRA:NASDAQ), 25.7%
- ATIF Holdings Limited (ATIF:NASDAQ), 23.6%